Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Analyses of sphingosine-1-phosphate in the context of transfusion: how much is in stored blood products and in patient blood?

Poppe A, Moritz E, Geffken M, Schreiber J, Greiwe G, Amschler K, Wruck ML, Schwedhelm E, Daum G, Kluge S, Peine S, Winkler MS.

Transfusion. 2019 Oct;59(10):3071-3076. doi: 10.1111/trf.15494. Epub 2019 Sep 4.

PMID:
31483505
2.

c-Rel is a cell cycle modulator in human melanoma cells.

Priebe MK, Dewert N, Amschler K, Erpenbeck L, Heinzerling L, Schön MP, Seitz CS, Lorenz VN.

Exp Dermatol. 2019 Feb;28(2):121-128. doi: 10.1111/exd.13848. Epub 2018 Dec 21.

PMID:
30466153
3.

Morphological Plasticity of Human Melanoma Cells Is Determined by Nanoscopic Patterns of E- and N-Cadherin Interactions.

Amschler K, Beyazpinar I, Erpenbeck L, Kruss S, Spatz JP, Schön MP.

J Invest Dermatol. 2019 Mar;139(3):562-572. doi: 10.1016/j.jid.2018.09.027. Epub 2018 Oct 28.

PMID:
30393081
4.

Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.

Amschler K, Mc Broekaert S, Mohr J, Schön MP, Mößner R.

Eur J Dermatol. 2018 Jun 1;28(3):403-405. doi: 10.1684/ejd.2018.3270. No abstract available.

PMID:
29976546
5.

Sensitization to diphenylmethane-diisocyanate isomers by a single accidental exposure.

Geier J, Amschler K, Claßen A, Buhl T.

Contact Dermatitis. 2018 Jan;78(1):90-92. doi: 10.1111/cod.12853. No abstract available.

PMID:
29265449
6.

Nanoscale Tuning of VCAM-1 Determines VLA-4-Dependent Melanoma Cell Plasticity on RGD Motifs.

Amschler K, Kossmann E, Erpenbeck L, Kruss S, Schill T, Schön M, Möckel SMC, Spatz JP, Schön MP.

Mol Cancer Res. 2018 Mar;16(3):528-542. doi: 10.1158/1541-7786.MCR-17-0272. Epub 2017 Dec 8.

7.

In search of a better patch test concentration for povidone-iodine.

Amschler K, Fuchs T, Geier J, Buhl T.

Contact Dermatitis. 2017 Nov;77(5):346-347. doi: 10.1111/cod.12838. No abstract available.

PMID:
29063684
8.

[Cutaneous manifestations of sarcoidosis].

Amschler K, Seitz CS.

Z Rheumatol. 2017 Jun;76(5):382-390. doi: 10.1007/s00393-017-0290-8. Review. German.

PMID:
28314915
9.

The IKKα-dependent non-canonical pathway of NF-κB activation is constitutively active and modulates progression-related functions in a subset of human melanomas.

Dewert N, Amschler K, Lorenz V, Schön MP.

Arch Dermatol Res. 2016 Dec;308(10):733-742. Epub 2016 Oct 15.

PMID:
27744496
10.

Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.

Amschler K, Meyersburg D, Kitze B, Schön MP, Mössner R.

Eur J Dermatol. 2016 Apr 1;26(2):211-2. doi: 10.1684/ejd.2015.2602. No abstract available.

PMID:
27125193
11.

Nanoscale integrin ligand patterns determine melanoma cell behavior.

Amschler K, Erpenbeck L, Kruss S, Schön MP.

ACS Nano. 2014 Sep 23;8(9):9113-25. doi: 10.1021/nn502690b. Epub 2014 Sep 3.

PMID:
25171587
12.

Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα.

Kruss S, Erpenbeck L, Amschler K, Mundinger TA, Boehm H, Helms HJ, Friede T, Andrews RK, Schön MP, Spatz JP.

ACS Nano. 2013 Nov 26;7(11):9984-96. doi: 10.1021/nn403923h. Epub 2013 Oct 4.

13.

Atypical location of lymphocytoma cutis in a child.

Amschler K, Schön MP, Mempel M, Zutt M.

Pediatr Dermatol. 2013 Sep-Oct;30(5):628-9. doi: 10.1111/pde.12166. Epub 2013 Jul 1.

PMID:
23808835
14.

NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.

Amschler K, Schön MP, Pletz N, Wallbrecht K, Erpenbeck L, Schön M.

J Invest Dermatol. 2010 Apr;130(4):1073-86. doi: 10.1038/jid.2009.365. Epub 2009 Nov 26.

15.

KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.

Schön M, Wienrich BG, Kneitz S, Sennefelder H, Amschler K, Vöhringer V, Weber O, Stiewe T, Ziegelbauer K, Schön MP.

J Natl Cancer Inst. 2008 Jun 18;100(12):862-75. doi: 10.1093/jnci/djn174. Epub 2008 Jun 10.

PMID:
18544741

Supplemental Content

Loading ...
Support Center